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Abstract: When discussing AED conversion in the clinic, both the patient and physician perspectives on the goals and 
risks of this change are important to consider. To identify patient-reported and clinician-perceived concerns, a panel of 
epilepsy specialists was questioned about the topics discussed with patients and the clinician’s perspective of patient con-
cerns. Findings of a literature review of articles that report patient-expressed concerns regarding their epilepsy and treat-
ment were also reviewed. Results showed that the specialist panel appropriately identified patient-reported concerns of 
driving ability, medication cost, seizure control, and medication side effects. Additionally, patient-reported concerns of 
independence, employment issues, social stigma, medication dependence, and undesirable cognitive effects are important 
to address when considering and initiating AED conversion.  
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INTRODUCTION 
  The objective of an antiepileptic drug (AED) conversion 
is to improve a patient’s quality of life (QoL). Successful 
conversion from one AED to another requires effective 
communication between the clinician and patient. Active 
patient involvement in the conversion decision, along with 
well-defined goals, will help to facilitate conversion. How-
ever, defining these goals may be difficult if the patient and 
the clinician have different perceptions and definitions of 
“success.” Patients with epilepsy are concerned with seizure 
control, social stigma, adverse effects of medication, and 
impairment of their cognitive ability [11]. While clinicians 
share these concerns, they may judge their relative impor-
tance differently compared to the patient perspective. For 
example, the patient may prioritize the decision on conver-
sion in the order of (low cost>seizure control>side effects), 
compared to the treating physician that may emphasize (sei-
zure control>side effects>cost).  
  In addition to these varying perspectives regarding the 
goals of therapy, the patient and clinician will often have 
different views on the risks of changing therapy. In order for 
clinicians to facilitate goal attainment by patients, they need 
to adequately address patient concerns about the AED con-
version process. In an effort to identify and compare the per-
spectives of tertiary referral epilepsy specialists to that of 
patients, this study reviewed the results of a Delphi panel of 
epileptologists questioned on their perceptions of patient 
concerns related to AED conversion. In addition, a literature 
review of patient-reported concerns regarding epilepsy and 
AED therapy was conducted. 
METHOD 
  A Study by Panel of Experts: Considerations for Therapy 
Replacement in Antiepileptics (SPECTRA) was convened to  
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develop consensus on how to convert patients from one AED 
to another. To reach consensus, the panel employed the Del-
phi method, a small-group technique involving a group of 
geographically dispersed experts [1] answering question-
naires designed to draw out individual responses to the issues 
posed and to facilitate the refining of views as the group pro-
ceeded to agreement through multiple rounds of questioning. 
The Delphi method avoids the disadvantages of other small-
group techniques by maintaining anonymity, controlling 
feedback, and providing statistically based responses [7]. 
  The literature review was performed using PubMed to 
identify research publications that addressed patient concerns 
regarding conversion of AEDs. The literature search identi-
fied articles that included the terms “patient” and “epilepsy 
drug” along with one of the following: “concerns,” “reluc-
tance,” “conversion,” or “perspective.” The search was lim-
ited to human subjects and publications in English.  
RESULTS  
Delphi Panel 
  By questionnaire, panel members were asked to identify 
topics they discuss with patients in regard to therapy conver-
sion and patient education. Table 1 lists these topics and fre-
quency details. Panel members were also asked to identify 
concerns that patients express to them with regard to therapy 
conversion. Table 2 lists these concerns and frequency de-
tails.  
  Panel members were subsequently asked to identify im-
portant topics that were missed during the rounds of ques-
tioning. Other topics that panel members identified included: 
teratogenicity in women and adverse effects of both the AED 
being replaced and the new agent being started. 
Literature Review 
  A total of 89 articles were identified from the literature 
review: 44 on patient AND concerns OR reluctance AND 
epilepsy drug; 18 on patient AND epilepsy drug conversion; Concerns with AED Conversion  Current Neuropharmacology, 2009, Vol. 7, No. 2    121
27 on patient perspective AND epilepsy drug. Articles were 
then reviewed based on relevance to identify patient con-
cerns regarding their epilepsy and AED therapy. A total of 
nine articles were identified as providing concerns expressed 
by patients.  
  Of these nine articles, three of them surveyed patient 
perceptions on several topics [5,6,8]. Select findings of these 
studies are presented in (Figs. 1 to 4). Four of the nine identi-
fied articles were narrower in scope and focused on a par-
ticular patient concern or issue [2-4,10]. Of the two remain-
ing articles, one provided a review of how patients perceive 
epilepsy and the other described the complex nature of vari-
ous issues surrounding epilepsy care [9,11].  
DISCUSSION 
  Successful AED conversion is facilitated by patient ac-
ceptance and adherence to therapy goals. In order to effec-
tively perform an AED conversion, patients and clinicians 
must work together to identify and address patient concerns 
regarding lifestyle, social, and medical factors. This paper 
compares patient and physician perceptions on AED conver-
Table  2.  Patient Concerns as Reported by the SPECTRA 
Panel  
Patient Concerns About Conversion n* (%)
Cost of medication 11 (92)
Loss/suspension of driving privilege 10 (83)
Potential loss of seizure control 10 (83)
New or worsening side effects 10 (83)
Drug interactions 8 (67)
Frequency of dosing 7 (58)
*n = number of individual panel members from the total panel size of 12 specialists 
who reported patient concerns 
Table  1.  Topics Reported by the SPECTRA Panel as Dis-
cussed with Patients 
Topics n* (%)
Goals of therapy (best QoL, no seizures, no side 
effects)
12 (100)
Likelihood of having a seizure during conversion 11 (92)
Education regarding difference between short- and 
long-term side effects
11 (92)
Importance of compliance during therapy conversion 9 (75)
Need to suspend driving 9 (75)
*n = number of individual panel members from the total panel size of 12 specialists 
who discussed the topic with patients. 
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sion. However, the ability to compare current physician per-
ceptions with those of patients from data obtained over the 
last decade is uncertain and may be limited in light of the 
significant changes in health care coverage and personal pa-
tient cost.  
Lifestyle and Social Factors 
  When facing a potential AED conversion, patients may 
be concerned about such lifestyle and social factors as driv-
ing ability, independence, work environment opportunities 
and prejudices, social stigma, and medication cost. The 
SPECTRA panel specified the loss or suspension of driving 
privileges as high on the list of patient concerns regarding 
AED conversion. Most countries impose driving restrictions 
upon people with epilepsy due to safety concerns [3]. Spe-
cific restrictions on driving vary substantially among juris-
dictions and are limited by available data on public and indi-
vidual risks [3]. The literature review showed that driving 
restrictions, risks and regulations were identified as an im-
portant lifestyle limitation by 11% to 28% of adults[5-8] and 
an even larger proportion (30%) of teenagers [2]. 
  The SPECTRA panel felt that cost of medication was a 
principle patient concern in AED conversion. In contrast to 
the panel findings, however, the literature indicates that cost 
may be of lesser concern for patients. In one previous study 
patients listed cost as last among seven criteria that factor 
into medication choice, [6] although the ability to compare 
Fig. (2). Patient-listed concerns as ‘Most Important’. 
Fig. (3). Patient-ranked areas of importance regarding seizure medication. Concerns with AED Conversion  Current Neuropharmacology, 2009, Vol. 7, No. 2    123
current physician perceptions with those of patients from this 
prior data from the last decade is uncertain. 
  Additional patient concerns regarding independence, 
work environment issues, or social stigma were frequently 
identified in the literature, indicating that these topics are of 
high concern to patients. Independence was identified as a 
concern by 54% of patients, with 9% stating that it was their 
most important concern [8]. Employment difficulties were 
reported by 8% of adults and 17% of those in school [5]. 
Employment was the most important concern for 21% of 
adult patients [8]. Education and career choices/opportunities 
were identified as a concern to 60% of teenage patients with 
epilepsy [2]. Social stigma was a concern for 24% of patients 
while embarrassment was a concern for 36% of patients 
[5,8]. Fear of other people’s reactions, shame, and with-
drawal from social interactions may lead to isolation and 
loneliness. As a result, these patient concerns may limit so-
cial integration and lifestyle behaviors. Researchers find that 
a patient’s QoL is adversely impacted when personal devel-
opment, self-esteem, and compromised relationships are im-
pacted by stigmatization [11]. By addressing concerns about 
independence, employment, and social stigma with the pa-
tient, the health care provider can enhance the AED conver-
sion process by allaying, or at least addressing, patient fears 
on how the medication conversion may impact their lives.  
Medical Therapy Concerns 
  From the patient’s perspective, medical therapy concerns 
include seizure control, medication side effects, medication 
dependence/safety issues, and cognitive effects. The SPEC-
TRA panel identified patient concerns as potential loss of 
seizure control, side effects, drug interactions, and dosing 
frequency. The panel members’ perception regarding the 
importance patients place on seizure control and side effects 
is substantiated by literature reports of patient concerns. 
  Seizure control was ranked as the highest area of impor-
tance by 41% of patients with epilepsy [6]. Seizure unpre-
dictability was identified as the most important patient con-
cern by 5% of patients, and another 5% listed seizure aver-
sion as the most important concern [8]. Fear as to when the 
next seizure may occur was reported by 32% of patients [5]. 
Patients reported that the single worst medicine outcome 
would be to make the seizures worse, with 91% of patients 
resisting medication change if there was a 1% chance of oc-
currence [6].  
  Side effects of AEDs were identified as the most impor-
tant concern by 5% to 35% of patients [6,8]. Teenage pa-
tients listed a concern regarding side effects and the possibil-
ity of withdrawing antiepileptic medication at 33% [2].  
  Medication dependence was a concern for 33% of pa-
tients, and 31% of patients were concerned with safety [8]. 
Patients believe that generic substitution can have negative 
results (68%) and that they are uncomfortable with generic 
antiepileptic medications (58%) [10]. Among adult patients, 
39% reported concern about their children having epilepsy or 
birth defects [5]. Among teenagers with epilepsy, 14% were 
concerned with contraception, pregnancy, and the inheri-
tance of epilepsy [2]. Drug interactions were not identified as 
a topic of patient concern in the literature, but convenience 
and dosage regimen simplicity was a concern for 23% of 
patients [6]. 
  The SPECTRA panel did not mention patient concerns 
associated with undesirable cognitive effects of AEDs. Con-
cerns with cognitive effects are reported by 40% to 50% of 
patients in school [5]. Improvements in cognition have been 
reported in QoL when patients are converted to monotherapy 
[4]. 
  Although this paper attempts to make an accurate analy-
sis of both patient and physician perspectives concerning the 
Fig. (4). Patient ratings of importance of perceived adverse effects of their current seizure medication. 124    Current Neuropharmacology, 2009, Vol. 7, No. 2 Smith et al. 
AED conversion process this paper has limitations including 
the design of the initial physician survey, the length of time 
needed for completion, and the relatively limited data ob-
tained from the literature review that actually addresses pa-
tients’ concerns with AED conversion. Also the SPECTRA 
panel was completed at a time prior to the present concerns 
with conversion to AED generic preparations.  
CONCLUSION 
  Understanding patient concerns about epilepsy and AEDs 
may be important to routine care when a change in medica-
tions is being considered or when the patient experiences a 
problem during AED conversion. Patients’ AED conversion 
concerns can be lessened by addressing lifestyle, social, and 
medical factors. Lifestyle and social factors include: driving 
ability, independence, work/school environment, social 
stigma, and costs. Medical factors include: seizure control, 
side effects, dependence/safety, and cognitive effects. Clini-
cian awareness of patient concerns will improve the AED 
conversion process. Patient education regarding the benefi-
cial impact of therapy conversion will enhance expectations 
on medical outcomes, allay fears on social impact, enhance 
compliance, and improve QoL. A clinical approach that 
stresses caution and explains potential risks and benefits 
prior to conversion, whether the conversion involves a new 
AED or change to a generic formulation, should be consid-
ered standard clinical practice.  
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